{"disease":{"id":"nonarteritic-anterior-ischemic-optic-neuropathy","name":"nonarteritic anterior ischemic optic neuropathy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03547206","title":"Efficacy & Safety of RPh201 Treatment in Patients With Previous Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":165,"lead_sponsor_name":"Regenera Pharma Ltd","has_results":false},{"nct_id":"NCT07330713","title":"Platelet-Rich Plasma for Acute Nonarteritic Anterior Ischemic Optic Neuropathy: A Prospective Randomized Controlled Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":31,"lead_sponsor_name":"Uludag University","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}